Full Text
Forecasting the United States Lifetime Cost and outcomes of Ivacaftor in Patients with Cystic Fibrosis

Abstract

Authors

P. Dilokthornsakul J.D. Campbell

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×